Advancements in immunotherapy for high-risk HR+ breast cancer

The Cancer Fight: Advancements in ImmunotherapyПодробнее

Dr. Ellis on Immunotherapy in HER2+ Breast CancerПодробнее

Key clinical trials investigating immunotherapy in HER2+ and HR+ breast cancerПодробнее

New directions in immunotherapy for improving outcomes in TNBCПодробнее

Understanding Breast CancerПодробнее

Immunotherapy Combinations for Advanced HR+ Breast Cancer: State-of-the-Science & Future DirectionsПодробнее

Breast Cancer Research and New AdvancesПодробнее

Immunotherapy for Breast and Pancreatic Cancers, with Elizabeth JaffeeПодробнее

Latest advances in immuno-oncology research in ER+ breast cancerПодробнее

Unlocking Immunotherapy for Breast CancerПодробнее

Encouraging developments in triple negative breast cancer immunotherapyПодробнее

First immunotherapy approved for breast cancerПодробнее

Latest Advances in Breast Cancer ResearchПодробнее

Recent Advances in Treating Breast Cancer Patients & Relevance of Immunotherapy with Case PresentatiПодробнее

Breast Cancer and the Immune System at MBC Patient Forum 2019Подробнее

I-SPY 2: immunotherapy biomarkers in early breast cancerПодробнее

Immunotherapy: What You Need To KnowПодробнее

Breast Cancer Clinical Trials: An Inside Look at ImmunotherapyПодробнее

Advances in Treatment of Triple-Negative Breast Cancer: A Success StoryПодробнее

Advances in Breast Cancer Treatment WebinarПодробнее